Insights
Practical reading for
owner decisions
Tax, accounting, and transition guidance written for owner-led companies in Idaho and Utah.
Stark Law and Anti-Kickback: Financial Arrangements to Avoid
Stark Law and Anti-Kickback rules govern physician financial arrangements. Here are five patterns that get practices in trouble and how FMV protects.
View DetailsStandard Costing vs. Actual Costing: Which Fits Your Plant?
Standard costing simplifies reporting; actual costing preserves fidelity. Learn which fits your plant and how to run useful variance analysis.
View DetailsSoil and Water Conservation Deductions (IRC §175) Explained
Drainage tile, terraces, water lines, contour furrows. Under the general rules, these land improvements get capitalized and depreciated slowly,...
View DetailsSKU-Level Profitability: How Retailers Find Hidden Losers
Blended margins mask money-losing SKUs. Learn the four-step allocation retailers use to surface true SKU profit and when to cut.
View DetailsSelling Your Practice to a DSO, MSO, or PPM: What to Expect
DSO, MSO, and PPM buyers pay differently, structure deals differently, and change your life differently. Here is what an owner-doctor should expect.
View DetailsSection 45X Advanced Manufacturing Credit
Section 45X pays per-unit credits for U.S.-produced solar, battery, and critical mineral components. See eligible components, phaseouts, and how to claim.
View DetailsSection 179 vs. Bonus Depreciation: A Medical Practice Guide
A physician buying $150,000 of new imaging or a dental office replacing four operatory chairs can write off far more in year one than most owners...
View DetailsSection 179 vs. Bonus Depreciation for Farm Equipment: Which One Wins on Your Next Purchase?
For Idaho and Utah farmers weighing a fall equipment purchase, the question is not whether to write it off. It is how. The tax code offers two paths,...
View DetailsSection 174 Rd Amortization Manufacturers
Section 174 changed again. Domestic R&D expensing is back for tax years after 2024. See what manufacturers should do now, and how foreign R&D differs.
View Details